These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17936957)

  • 1. Risks versus benefits of long-term proton pump inhibitor therapy in the elderly.
    Schuler A
    Geriatr Nurs; 2007; 28(4):225-9. PubMed ID: 17936957
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Madanick RD
    Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. We Are Using Too Many PPIs, and We Need to Stop: A European Perspective.
    Lanas A
    Am J Gastroenterol; 2016 Aug; 111(8):1085-6. PubMed ID: 27166129
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

  • 6. Proton Pump Inhibitors and Bone Health: What the Orthopaedic Surgeon Needs to Know.
    Wagner SC
    JBJS Rev; 2018 Dec; 6(12):e6. PubMed ID: 30562209
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium difficile infection in hospitals: risk factors and responses.
    Louie TJ; Meddings J
    CMAJ; 2004 Jul; 171(1):45-6. PubMed ID: 15238495
    [No Abstract]   [Full Text] [Related]  

  • 8. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
    Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
    Armstrong D
    Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term safety concerns with proton pump inhibitors.
    Ali T; Roberts DN; Tierney WM
    Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What you should know about: PPIs.
    Harv Health Lett; 2013 Feb; 38(4):7. PubMed ID: 23841173
    [No Abstract]   [Full Text] [Related]  

  • 12. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
    O'Connor HJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 15. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.
    Sanders SW
    Clin Ther; 1996; 18(1):2-34; discussion 1. PubMed ID: 8851451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional consequences of long-term acid suppression; are they clinically important?
    Johnson DA
    Curr Opin Gastroenterol; 2016 Mar; 32(2):136-40. PubMed ID: 26760397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent acid inhibition: summary of the evidence and clinical application.
    Mearin F; Ponce J
    Drugs; 2005; 65 Suppl 1():113-26. PubMed ID: 16335865
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease.
    Vakil N; Fennerty MB
    Aliment Pharmacol Ther; 2003 Sep; 18(6):559-68. PubMed ID: 12969082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.